Showing 4,461 - 4,480 results of 16,260 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 0.61s Refine Results
  1. 4461

    Toxic activity of AS56 on the larval feeding behavior of <i>S. exigua.</i> by Niayesh Shahmohammadi (21262234)

    Published 2025
    “…<p>(A) Median lethal concentration (LC50) and median lethal time (LT50) of AS56 across various developmental stages (L1, L3, and L5) of S. exigua using the leaf-dipping method. …”
  2. 4462
  3. 4463
  4. 4464
  5. 4465
  6. 4466
  7. 4467

    NF-κB p65 and phosphorylation of IκBα <i>in vitro</i>. by Naoki Takada (2728912)

    Published 2021
    “…<p>(A) The enzyme-linked immunosorbent assay (ELISA) results showed that p65 concentration in the radiation group was higher than that in the control group (NOZ: 2,398.4 ± 62.8 ng/mg protein vs. 923.5 ± 42.3 ng/mg protein, p < 0.01; OCUG-1: 2,609.3 ± 409.3 ng/mg protein vs. 1,899.5 ± 99.5 ng/mg protein, p < 0.05). p65 concentration in the combination group was lower than that in the radiation group (NOZ: 1,256.1 ± 13.0 ng/mg protein vs. 2,398.4 ± 62.8 ng/mg protein, p < 0.01; OCUG-1: 1,250.9 ± 117.8 ng/mg protein vs. 2,609.3 ± 409.3 ng/mg protein, p < 0.01). …”
  8. 4468
  9. 4469

    New advances in <i>DPYD</i> genotype and risk of severe toxicity under capecitabine - Fig 3 by Marie-Christine Etienne-Grimaldi (413881)

    Published 2017
    “…<p>Distribution of pre-treatment plasma UH2/U ratio (A) and Uracil concentrations (B) for the 205 patients with validated phenotypic data, according to <i>DPYD</i> variants of interest: variant *2A (3 heterozygous patients), D949V (3 heterozygous patients), R592W (1 heterozygous patient), D342G (1 heterozygous patient), HapB3 (4 heterozygous patients), 166VV (3 homozygous patients) <i>vs</i> any other variations (185 patients) <i>vs</i> no variation (5 patients). …”
  10. 4470

    Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

    Published 2025
    “…Collectively, statins significantly reduced IL-6 (<i>MD = -0.24</i> ng/dL <i>[95% CI, -0.36 to -0.13], I</i><sup><i>2</i></sup> <i>= 98.3%, p < 0.001</i>), TNF-α (<i>MD = -0.74</i> ng/dL <i>[95% CI, -1.08 to -0.40], I</i><sup><i>2</i></sup> <i>= 98.8%, p < 0.001</i>); and CRP (<i>MD = -1.58</i> mg/L <i>[95% CI, -2.22 to -0.94], I</i><sup><i>2</i></sup> <i>= 86.5%, p < 0.001</i>). …”
  11. 4471

    Newcastle-Ottawa scale. by Solima Sabeel (9545738)

    Published 2025
    “…Collectively, statins significantly reduced IL-6 (<i>MD = -0.24</i> ng/dL <i>[95% CI, -0.36 to -0.13], I</i><sup><i>2</i></sup> <i>= 98.3%, p < 0.001</i>), TNF-α (<i>MD = -0.74</i> ng/dL <i>[95% CI, -1.08 to -0.40], I</i><sup><i>2</i></sup> <i>= 98.8%, p < 0.001</i>); and CRP (<i>MD = -1.58</i> mg/L <i>[95% CI, -2.22 to -0.94], I</i><sup><i>2</i></sup> <i>= 86.5%, p < 0.001</i>). …”
  12. 4472
  13. 4473

    NF-κB and apoptotic signals <i>in vivo</i>. by Naoki Takada (2728912)

    Published 2021
    “…<p>(A) p65 concentration in the excised tumors significantly increased in the radiation group compared with that in the control group (893.6 ± 91.0 ng/mg protein vs. 628.5 ± 146.1 ng/mg protein, p < 0.05). p65 expression in the combination group was lower than that in the radiation group (375.93 ± 201.3 ng/mg protein vs. 893.6 ± 91.0 ng/mg protein, p < 0.01). …”
  14. 4474
  15. 4475
  16. 4476
  17. 4477
  18. 4478
  19. 4479
  20. 4480